Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2005; 93(01): 172-174
DOI: 10.1055/s-0037-1617410
DOI: 10.1055/s-0037-1617410
Case Report
Fibroblast growth factor 2 and the transcription factor Egr-1 localise to endothelial cell microvascular channels in human coronary artery occlusion
Authors
Further Information
Correspondence to:
Harry C. Lowe
Centre for Vascular Research
School of Medical Sciences
University of New South Wales
Sydney NSW 2052, Australia
Phone: 61 2 9767 6296
Fax: 61 2 9767 6994
Email: h.lowe@unsw.edu.au
Publication History
Received
14 June 2004
Accepted after resubmission
25 October 2004
Publication Date:
15 December 2017 (online)
Scroll to top
-
References
- 1 Bailey SR. Opportunity lost: the continuing challenge of chronic total occlusions. Catheter Cardiovasc Interv 2003; 59: 312-3.
- 2 Srivatsa SS, Edwards WD, Boos CM. et al Histologic correlates of angiographic chronic total coronary artery occlusions: influence of occlusion duration on neovascular channel patterns and intimal plaque composition. J Am Coll Cardiol 1997; 29: 955-63.
- 3 Szebenyi G, Fallon JF. Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 1999; 185: 45-106.
- 4 Detillieux KA, Sheikh F, Kardami E. et al Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 2003; 57: 8-19.
- 5 Khachigian LM, Collins T. Inducible expression of Egr-1-dependent genes. A paradigm of transcriptional activation in vascular endothelium. Circ Res 1997; 81: 457-61.
- 6 Santiago FS, Lowe HC, Day FL. et al Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor- 2. Am J Pathol 1999; 154: 937-44.
- 7 Fahmy RG, Dass CR, Sun LQ. et al Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med 2003; 9: 1026-32.
- 8 Neufeld G, Cohen T, Gengrinovitch S. et al Vascular endothelial growth factor (VEGF) and its receptors. FASEB 1999; 13: 9-22.
- 9 Waltham M, Burnand KG, Collins M. et al Vascular endothelial growth factor enhances venous thrombus recanalisation and organisation. Thromb Haemost 2003; 89: 169-76.
- 10 Deindl E, Buschmann I, Hoefer IE. et al Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ Res 2001; 89: 779-86.
- 11 Yan SF, Mackman N, Kisiel W. et al Hypoxia / Hypoxemia Induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis. Arterioscler Thromb Vasc Biol 1999; 19: 2029-35.
- 12 Aviles RJ, Annex BH, Lederman RJ. Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF-2). Br J Pharmacol 2003; 140: 637-46.
Correspondence to:
Harry C. Lowe
Centre for Vascular Research
School of Medical Sciences
University of New South Wales
Sydney NSW 2052, Australia
Phone: 61 2 9767 6296
Fax: 61 2 9767 6994
Email: h.lowe@unsw.edu.au
-
References
- 1 Bailey SR. Opportunity lost: the continuing challenge of chronic total occlusions. Catheter Cardiovasc Interv 2003; 59: 312-3.
- 2 Srivatsa SS, Edwards WD, Boos CM. et al Histologic correlates of angiographic chronic total coronary artery occlusions: influence of occlusion duration on neovascular channel patterns and intimal plaque composition. J Am Coll Cardiol 1997; 29: 955-63.
- 3 Szebenyi G, Fallon JF. Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 1999; 185: 45-106.
- 4 Detillieux KA, Sheikh F, Kardami E. et al Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 2003; 57: 8-19.
- 5 Khachigian LM, Collins T. Inducible expression of Egr-1-dependent genes. A paradigm of transcriptional activation in vascular endothelium. Circ Res 1997; 81: 457-61.
- 6 Santiago FS, Lowe HC, Day FL. et al Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor- 2. Am J Pathol 1999; 154: 937-44.
- 7 Fahmy RG, Dass CR, Sun LQ. et al Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med 2003; 9: 1026-32.
- 8 Neufeld G, Cohen T, Gengrinovitch S. et al Vascular endothelial growth factor (VEGF) and its receptors. FASEB 1999; 13: 9-22.
- 9 Waltham M, Burnand KG, Collins M. et al Vascular endothelial growth factor enhances venous thrombus recanalisation and organisation. Thromb Haemost 2003; 89: 169-76.
- 10 Deindl E, Buschmann I, Hoefer IE. et al Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ Res 2001; 89: 779-86.
- 11 Yan SF, Mackman N, Kisiel W. et al Hypoxia / Hypoxemia Induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis. Arterioscler Thromb Vasc Biol 1999; 19: 2029-35.
- 12 Aviles RJ, Annex BH, Lederman RJ. Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF-2). Br J Pharmacol 2003; 140: 637-46.